OSSF.F Stock Overview
Provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Embla Medical hf. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 5.02 |
| 52 Week High | DKK 5.10 |
| 52 Week Low | DKK 4.03 |
| Beta | 0.63 |
| 11 Month Change | 4.33% |
| 3 Month Change | 12.19% |
| 1 Year Change | n/a |
| 33 Year Change | -22.25% |
| 5 Year Change | -30.83% |
| Change since IPO | 25.69% |
Recent News & Updates
Recent updates
Shareholder Returns
| OSSF.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -1.7% | -1.2% | -2.1% |
| 1Y | n/a | 22.4% | 29.6% |
Return vs Industry: Insufficient data to determine how OSSF.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how OSSF.F performed against the US Market.
Price Volatility
| OSSF.F volatility | |
|---|---|
| OSSF.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: OSSF.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine OSSF.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1971 | 4,000 | Sveinn Solvason | www.emblamedical.com |
Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics, Bracing & Supports, and Patient Care. The Prosthetics segment offers mechanical products, such as lower limb prosthetics and finger prostheses; and bionic products microprocessor-controlled feet, knees, hands, liners, fingers, and other components integrated.
Embla Medical hf. Fundamentals Summary
| OSSF.F fundamental statistics | |
|---|---|
| Market cap | US$2.16b |
| Earnings (TTM) | US$69.07m |
| Revenue (TTM) | US$840.31m |
31.3x
P/E Ratio2.6x
P/S RatioIs OSSF.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OSSF.F income statement (TTM) | |
|---|---|
| Revenue | US$840.31m |
| Cost of Revenue | US$319.17m |
| Gross Profit | US$521.13m |
| Other Expenses | US$452.07m |
| Earnings | US$69.07m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 05, 2025
| Earnings per share (EPS) | 0.16 |
| Gross Margin | 62.02% |
| Net Profit Margin | 8.22% |
| Debt/Equity Ratio | 50.7% |
How did OSSF.F perform over the long term?
See historical performance and comparison